naftopidil has been researched along with Bladder, Overactive in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funahashi, Y; Gotoh, M; Kato, M; Majima, T; Matsukawa, Y; Takai, S | 1 |
| Guo, KC; Huo, LZ; Jing, HG; Luan, XH; Shi, BK; Wang, TC; Yuan, SX | 1 |
| Anai, S; Asakawa, I; Fujimoto, K; Hasegawa, M; Hirayama, A; Konishi, N; Miyake, M; Tanaka, N; Torimoto, K | 1 |
| Asai, K; Gotoh, M; Kashiwagi, Y; Kasugai, S; Kato, M; Komatsu, T; Matsukawa, Y; Narita, H; Takai, S; Yamamoto, T | 1 |
| Ito, N; Kamiyama, Y; Kanamaru, S; Kawakita, M; Matsumoto, K; Muguruma, K; Shirahase, T; Takahashi, T; Tsukazaki, H; Tsunemori, H; Utsunomiya, N | 1 |
| Funahashi, Y; Gotoh, M; Kato, M; Majima, T; Matsukawa, Y; Narita, H; Ogawa, T; Takai, S | 1 |
| Carson, CC | 1 |
| Aizawa, N; Andersson, KE; Chen, Z; Igawa, Y; Imamura, T; Ishizuka, O; Nishizawa, O | 1 |
| Gao, JP; Ge, JP; Gong, J; Ma, HQ; Shang, XJ; Wang, D; Wei, W; Xu, S; Zhang, ZY | 1 |
| Oh-oka, H | 1 |
| Kumon, H; Nagai, A; Sasaki, K; Uematsu, K; Watanabe, T; Yokoyama, T | 1 |
| Aoki, D; Furukawa, M; Hakariya, T; Hayashi, M; Igawa, T; Kanetake, H; Matsuya, F; Nishimura, N; Nomata, K; Onita, T; Sakai, H; Shida, Y; Shiraishi, K; Shono, T; Takehara, K; Tsurusaki, T; Yogi, Y | 1 |
| Abe, K; Egaway, S; Furuta, A; Ikemoto, I; Kishimoto, K; Kiyota, H; Kosugi, S; Shimomura, T; Shirai, H; Suzuki, Y; Takeuchi, H; Torii, S | 1 |
| Kadekawa, K; Miyazato, M; Nishijima, S; Ogawa, Y; Sugaya, K; Tasaki, S | 1 |
9 trial(s) available for naftopidil and Bladder, Overactive
| Article | Year |
|---|---|
What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms?
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder, Overactive | 2019 |
[A combination of solifenacin succinate and naftopidil in the treatment of female overactive bladder].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Young Adult | 2013 |
Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Brachytherapy; Humans; Indoles; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Neoplasms; Urinary Bladder, Overactive | 2014 |
A Slow Stream Is Pathophysiologically Related to a Poor Response to α1-Adrenoceptor Therapy in the Treatment of Storage Symptoms Associated With Benign Prostatic Hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder, Overactive; Urination | 2015 |
[A Crossover Comparison Study on Lower Urinary Tract Symptoms with Overactive Bladder Secondary to Benign Prostatic Hyperplasia: Naftopidil versus Tamsulosin with Solifenacin].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive | 2016 |
Comparison of Silodosin and Naftopidil for Efficacy in the Treatment of Benign Prostatic Enlargement Complicated by Overactive Bladder: A Randomized, Prospective Study (SNIPER Study).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Receptors, Adrenergic, alpha-1; Treatment Outcome; Urinary Bladder, Overactive; Urination; Urodynamics | 2017 |
[Effectiveness and safety of naftopidil for benign prostatic hyperplasia patients with overactive bladder symptoms].
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Urinary Bladder, Overactive | 2008 |
Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
Topics: Adrenergic alpha-Antagonists; Aged; Benzilates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder, Overactive; Urination; Urologic Diseases | 2009 |
[Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia: prospective randomized controlled study to compare differences in efficacy between morning and evening medication].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Urinary Bladder, Overactive | 2011 |
6 other study(ies) available for naftopidil and Bladder, Overactive
| Article | Year |
|---|---|
Topics: Adrenergic alpha-Antagonists; Humans; Indoles; Naphthalenes; Piperazines; Prospective Studies; Urinary Bladder, Overactive | 2017 |
Editorial Comment.
Topics: Humans; Indoles; Male; Naphthalenes; Piperazines; Prospective Studies; Urinary Bladder, Overactive | 2017 |
Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Body Temperature; Cold Temperature; Female; Indoles; Naphthalenes; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urinary Bladder; Urinary Bladder, Overactive | 2009 |
Usefulness of naftopidil for dysuria in benign prostatic hyperplasia and its optimal dose--comparison between 75 and 50 mg.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Compliance; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysuria; Humans; Male; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics | 2009 |
[A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia with overactive bladder].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Bladder, Overactive | 2007 |
Effects of propiverine and naftopidil on the urinary ATP level and bladder activity after bladder stimulation in rats.
Topics: Acetic Acid; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Benzilates; Cholinergic Antagonists; Drug Interactions; Energy Metabolism; Female; Muscle Contraction; Muscle, Smooth; Naphthalenes; Piperazines; Pressure; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Muscarinic; Urinary Bladder; Urinary Bladder, Overactive; Urothelium | 2007 |